Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.
about
Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cellsBispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugatesCell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.Enhanced antigen immunogenicity induced by bispecific antibodies.Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell.Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.The immunotherapy of human cancer with interleukin 2: present status and future directions.Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.Non-antigen-specific triggering signals for human cytotoxic T lymphocytes.The induction of T cell-mediated cytolysis by monoclonal antibodies against the T cell receptor/CD3 complex.Prospects for clinical cancer treatment using interleukin-2.Targeting of cytotoxic cells with heterocrosslinked antibodies.Bispecific monoclonal antibody therapy of B-cell malignancy.Bispecific antibodies in lymphoma.Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells.A new form of specific targeting cancer immunotherapy using anti-tumor monoclonal antibody-conjugated lymphokine-activated killer cells.
P2860
Q33656364-E32B3054-9DC5-4C60-9FC8-F45F231FDD61Q34517676-894C62C3-3516-454E-B011-0A231EEEF8A0Q35612033-006B412E-3523-4AAF-B22F-E6E6F93DE40BQ35822603-394E4328-B591-492B-9DB7-0F9FD9920842Q36351292-DEB4F9BE-B70D-4C15-A70D-DCC5524065CEQ36356552-DB5A2C24-46A9-4AFA-8E0C-CF32C999C8A9Q37403988-B936B223-232C-4F14-8333-E6D5BD6BB2F3Q37427683-1822CD1C-568C-4124-9BCC-8BE12A75332BQ37737788-CD41FDFC-1E84-45F2-854C-247ED276201DQ38263240-C10A0BB2-2176-4021-BF91-4D8F6D499B65Q38378573-89448795-E38F-42D5-9831-1D700248AFA5Q38764662-AE13B4E7-0DF4-4C4C-8E0F-B649C7EF186FQ39639738-35DFF329-91A6-4A14-900B-D86A8C9781FCQ40507887-15B3539B-A936-4465-AB25-C0A6EE9CB37DQ40840169-529B7AD4-41B6-4536-BE7A-A00EB0815228Q40922699-F3948EC7-D631-49EC-BF73-B380AA52377EQ41017130-E1628025-F82E-494E-86B0-CBBB9EEF662EQ41681428-A66013AA-9735-4F54-BE65-3A66F35BC01D
P2860
Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Specific targeting of human pe ...... o anti-target cell antibodies.
@ast
Specific targeting of human pe ...... o anti-target cell antibodies.
@en
type
label
Specific targeting of human pe ...... o anti-target cell antibodies.
@ast
Specific targeting of human pe ...... o anti-target cell antibodies.
@en
prefLabel
Specific targeting of human pe ...... o anti-target cell antibodies.
@ast
Specific targeting of human pe ...... o anti-target cell antibodies.
@en
P2093
P2860
P356
P1476
Specific targeting of human pe ...... o anti-target cell antibodies.
@en
P2093
P2860
P304
P356
10.1084/JEM.163.1.166
P407
P577
1986-01-01T00:00:00Z